Screening Guidelines: Cervical Cancer Screening References

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun, MJ. Cancer Statistics, 2009. CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. Epub 2009 May 27. [PubMed Abstract]
  2. Sepulveda C, Prado R. Effective cervical cytology screening programmes in middle-income countries: the Chilean experience. Cancer Detect Prev. 2005;29:405-11. Epub 2005 Sep 26. [PubMed Abstract]
  3. Chi DS, Abu-Rustum NR, Hoskins WJ. Cancer of the Cervix. In: Rock JA, Jones HW III, eds. Te Linde’s Operative Gynecology, 9th ed. Philadelphia: Lippincott, Williams & Wilkins, 2003.
  4. American Cancer Society (ACS) Guidelines for the Early Detection of Cancer. Available at www.cancer.org.
  5. American College of Obstetricians and Gynecologists. Cervical cytology screening. ACOG Practice Bulletin No. 109. Obstet Gynecol. 2009 Dec;114(6):1409-20. [PubMed Abstract]
  6. National Comprehensive Cancer Network (NCCN) clinical practice guidelines in oncology, cervical screening version 1, 2009.
  7. The National Cancer Institute (NCI) guidelines on cervical cancer screening by the US Preventive Services Task Force (USPSTF), 2003.
  8. Gershenson DM, Copeland LJ, Hoskins WJ, Podratz KC (editors). Reducing the burden of HPV and HPV related diseases: An update for primary care practitioners. Gynecologic Oncology. 2007;107(2): S31-33. [PubMed Abstract]
  9. Human Papillomavirus Vaccination. ACOG Committee Opinion No. 344. American College of Obstetricians and Gynecologists. September 2006.
  10. Hildeshiem A, Berrington de Gonzalez A. Etiology and prevention of cervical adenocarcinomas. J Natl Cancer Inst. 2006 Mar 1;98(5):292-3. [PubMed Abstract]
  11. D’Souza, G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007 May 10;356(19):1944-56. [PubMed Abstract]
  12. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007 May 10;356(19):1915-27. [PubMed Abstract]
  13. Garland, SM, Hernandez-Avila, M, Wheeler, CM, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. NEJM, 2007;356:1928-1943. [PubMed Abstract]
  14. The FUTURE II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neopalsia grade 2, grade 3, and adenocarcinoma in situ: A combined analysis of four randomised clinical trials. Lancet. 2007 May 31;369(9,576):1861-8. [PubMed Abstract]
  15. Advisory Committee on Immunization Practices (ACIP) HPV recommendations. Available at www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm?s_cid=rr5602a1_e. Accessed January 29, 2008.
  16. American College of Obstetricians and Gynecologists (ACOG) HPV recommendations. Available at www.acog.org/departments/dept_notice.cfm?recno=7&bulletin=3945. Accessed January 29, 2008.
  17. American Academy of Pediatrics (AAP) HPV recommendations. Available at www.cispimmunize.org. Accessed January 29, 2008.
  18. Society of Gynecologic Oncologists (SGO) HPV recommendations. Available at www.sgo.org/content.aspx?id=394. Accessed January 29, 2008.
  19. American Cancer Society (ACS) HPV recommendations. Available at www.cancer.org/docroot/CRI/content/CRI_2_6x_FAQ_HPV_Vaccines.asp. Accessed January 29, 2008.